Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease

There is paucity of data on extended dosing interval between two doses of AZD1222 (AstraZeneca) in patients with Autoimmune Rheumatic Diseases (AIRD). We aimed to study the humoral response and rate of breakthrough infections between the two groups who had received the second dose of vaccine at 4 we...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Pankti, Paul, Aby, Ahmed, Sakir, Cherian, Somy, Panthak, Ameya, Benny, Janet, Shenoy, Padmanabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244552/
https://www.ncbi.nlm.nih.gov/pubmed/35760938
http://dx.doi.org/10.1007/s10067-022-06247-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244552/
https://www.ncbi.nlm.nih.gov/pubmed/35760938
http://dx.doi.org/10.1007/s10067-022-06247-3

Ejemplares similares